Anakinra is a recombinant interleukin (IL)-1 receptor antagonistusedforseveralinflammatoryconditionsincludingsystemicjuvenileidiopathicarthritis,recurrentpericarditis,andfamilialMediterraneanfever (FMF). Its efficacy in blocking IL-1 and its manageable safetyprofilesupportitsusealsoinotherconditions,suchassepsis,acutemyocardialinfarction,andCOVID-19

IL-1 blockade with anakinra for severe inflammatory symptoms during chemotherapy for acute lymphoblastic leukemia

Naviglio S.;Zanella G.
;
Verzegnassi F.;Kiren V.;Giurici N.;Valencic E.;Tommasini A.;Rabusin M.
2022-01-01

Abstract

Anakinra is a recombinant interleukin (IL)-1 receptor antagonistusedforseveralinflammatoryconditionsincludingsystemicjuvenileidiopathicarthritis,recurrentpericarditis,andfamilialMediterraneanfever (FMF). Its efficacy in blocking IL-1 and its manageable safetyprofilesupportitsusealsoinotherconditions,suchassepsis,acutemyocardialinfarction,andCOVID-19
9-ott-2021
Pubblicato
https://onlinelibrary.wiley.com/doi/10.1002/pbc.29404
File in questo prodotto:
File Dimensione Formato  
Pediatric Blood Cancer - 2021 - Naviglio - IL‐1 blockade with anakinra for severe inflammatory symptoms during.pdf

Accesso chiuso

Tipologia: Documento in Versione Editoriale
Licenza: Copyright Editore
Dimensione 321.94 kB
Formato Adobe PDF
321.94 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
3015300_Pediatric Blood Cancer - 2021 - Naviglio - IL‐1 blockade with anakinra for severe inflammatory symptoms during-Post_print.pdf

Open Access dal 10/10/2022

Tipologia: Bozza finale post-referaggio (post-print)
Licenza: Digital Rights Management non definito
Dimensione 874.09 kB
Formato Adobe PDF
874.09 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11368/3015300
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact